Financial Year |
March 31 2023 |
Monetary Funds |
540,713,988.57 |
Held-for-trading Financial Assets |
5,123,721.20 |
Notes Receivable |
-- |
Accounts Receivable |
55,214,788.03 |
Advances to Suppliers |
92,629,411.41 |
Other Receivables |
123,474,722.90 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
11,304,583.20 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
43,715,270.15 |
Total Current Assets |
872,176,485.46 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
101,630,306.54 |
Investment Properties |
12,908,058.67 |
Fixed Assetes |
467,959,074.15 |
Under-construction Projects |
20,863,520.08 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
20,392,524.15 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
440,932,118.90 |
Deferred Income Tax Assets |
43,279,769.48 |
Other Non-Current Assets |
2,462,881.77 |
Sub-Total of Non-Current Assets |
3,625,894,030.87 |
Total Assets |
4,498,070,516.33 |
Short-Term Loans |
275,576,812.55 |
Trading Financial liabilities |
-- |
Notes Payable |
19,987,093.28 |
Accounts Payable |
219,764,265.02 |
Accounts Received In Advance |
507,307.90 |
Employee Compensation Payable |
14,825,150.47 |
Taxes Payable |
11,958,390.49 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
19,844,106.39 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
328,941,410.09 |
Other Current Liabilities |
-- |
Sub-Total of Current Liabilities |
1,219,324,359.82 |
Long-term Loans |
163,839,749.68 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
3,109,699,720.88 |
Total Liabilities |
4,329,024,080.70 |
Paid-In Capital(Or Share Stock) |
376,320,000.00 |
Capital Surplus |
577,264,216.18 |
Surplus Reserve |
132,112,307.23 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-932,987,393.26 |
Minority Stockholder's Interest |
5,676,184.41 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
163,370,251.22 |
Owner's Equity(Stockholder's Equity) |
169,046,435.63 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
4,498,070,516.33 |